Literature DB >> 10908170

Mutations in the CYP21 B gene in a Chilean population with simple virilizing congenital adrenal hyperplasia.

C E Fardella1, H Poggi, J Soto, I Torrealba, A Cattani, F Ugarte, A Cortinez, A Foradori.   

Abstract

Steroid 21-hydroxylase deficiency (21OHD) compromises about 95% of all cases of congenital adrenal hyperplasia. We have characterized the disease-causing mutations in the steroid 21-hydroxylase genes of 19 Chilean patients (12 females and 7 males) with the simple virilizing (SV) form of 21OHD and compared them with other SV-populations. Using allele-specific polymerase chain reaction, we identified lesions in 28 chromosomes out of 38 tested (73.7%). The most frequent finding was the mutation I173N=12/38 (31.6%) similar as described in Caucasian, Asian and other Hispanic populations, where this mutation represents around 20-40% of the genetic defects in the CYP21B gene. The mutation V282L=4/38 (10.5%) and deletion (Del) or large gene conversion (LGC)=3/38 (7.9%) were also frequently detected. Only 2 alleles carried the mutation I2 splice (5.3%), this frequency is lower than that reported in Caucasian or in Mexican populations. We did not find alleles with the mutations R357W, Cluster E6, P31L and P454S in these patients. The complete genotype was determined in 11/19 patients (58%) and one allele in 6/19 patients (31.6%). In summary, about 30% of the Chilean population with SV 21OHD presented the missense mutation I173N as described in other populations. The frequency of the other lesions showed differences even between populations with similar genetic background.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10908170     DOI: 10.1007/BF03343746

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN: 0391-4097            Impact factor:   4.256


  28 in total

1.  Gene frequencies and admixture estimates in four Mexican urban centers.

Authors:  R Lisker; E Ramirez; R P Briceño; J Granados; V Babinsky
Journal:  Hum Biol       Date:  1990-12       Impact factor: 0.553

Review 2.  Clinical and molecular genetics of congenital adrenal hyperplasia due to 21-hydroxylase deficiency.

Authors:  Y Morel; W L Miller
Journal:  Adv Hum Genet       Date:  1991

Review 3.  Molecular genetics of congenital adrenal hyperplasia (21-hydroxylase deficiency): implications for diagnosis, prognosis and treatment.

Authors:  A Wedell
Journal:  Acta Paediatr       Date:  1998-02       Impact factor: 2.299

Review 4.  Molecular approaches for the diagnosis of 21-hydroxylase deficiency and congenital adrenal hyperplasia.

Authors:  A Wedell
Journal:  Clin Lab Med       Date:  1996-03       Impact factor: 1.935

5.  American Indian prehistory as written in the mitochondrial DNA: a review.

Authors:  D C Wallace; A Torroni
Journal:  Hum Biol       Date:  1992-06       Impact factor: 0.553

Review 6.  Molecular biology of mineralocorticoid metabolism.

Authors:  C E Fardella; W L Miller
Journal:  Annu Rev Nutr       Date:  1996       Impact factor: 11.848

7.  Mutations of the steroid 21-hydroxylase gene in an Argentinian population of 36 patients with classical congenital adrenal hyperplasia.

Authors:  A Dardis; I Bergada; C Bergada; M Rivarola; A Belgorosky
Journal:  J Pediatr Endocrinol Metab       Date:  1997 Jan-Feb       Impact factor: 1.634

8.  Genetic epidemiology of single gene defects in Chile.

Authors:  R Cruz-Coke; R S Moreno
Journal:  J Med Genet       Date:  1994-09       Impact factor: 6.318

9.  Complete nucleotide sequence of two steroid 21-hydroxylase genes tandemly arranged in human chromosome: a pseudogene and a genuine gene.

Authors:  Y Higashi; H Yoshioka; M Yamane; O Gotoh; Y Fujii-Kuriyama
Journal:  Proc Natl Acad Sci U S A       Date:  1986-05       Impact factor: 11.205

Review 10.  Rapid deoxyribonucleic acid analysis by allele-specific polymerase chain reaction for detection of mutations in the steroid 21-hydroxylase gene.

Authors:  R C Wilson; J Q Wei; K C Cheng; A B Mercado; M I New
Journal:  J Clin Endocrinol Metab       Date:  1995-05       Impact factor: 5.958

View more
  3 in total

1.  Development of CYP21A2 Genotyping Assay for the Diagnosis of Congenital Adrenal Hyperplasia.

Authors:  Mayara Jorgens Prado; Simone Martins de Castro; Cristiane Kopacek; Maricilda Palandi de Mello; Thaiane Rispoli; Tarciana Grandi; Cláudia Maria Dornelles da Silva; Maria Lucia Rosa Rossetti
Journal:  Mol Diagn Ther       Date:  2017-12       Impact factor: 4.074

2.  Molecular diagnosis of patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency.

Authors:  Tania Mayvel Espinosa Reyes; Teresa Collazo Mesa; Paulina Arasely Lantigua Cruz; Adriana Agramonte Machado; Emma Domínguez Alonso; Henrik Falhammar
Journal:  BMC Endocr Disord       Date:  2020-11-09       Impact factor: 2.763

Review 3.  Characteristics of In2G Variant in Congenital Adrenal Hyperplasia Due to 21-Hydroxylase Deficiency.

Authors:  Mirjana Kocova; Paola Concolino; Henrik Falhammar
Journal:  Front Endocrinol (Lausanne)       Date:  2022-01-24       Impact factor: 5.555

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.